Senior Director, Global Study Start Up

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube.

The Senior Director, Global Study Start-Up (SSU) is accountable for leading study start-up strategy, talent, and execution across the AbbVie portfolio. This role oversees AbbVie Global Study Startup group and drives consistent, high-quality delivery of global start-up milestones through strong talent leadership, proactive risk management, standardized and continuously improved processes, and scaled adoption of AI-enabled ways of working. The Senior Director serves as a key business partner across Clinical Study Leadership, Regulatory, Clinical Site Management, and other stakeholders to accelerate study activation while maintaining compliance. This role reports into Vice President, Neuroscience Clinical Study Leadership and Global Study Start Up.

Responsibilities

Key Stakeholders: R&D Leadership team, Country Affiliate leadership

Responsibilities

Define and execute the long-term vision, strategy, and operating model for the Global Study Start-Up organization.; Establish enterprise standards, governance, and performance expectations across therapeutic areas and geographies.; Drive organizational design and workforce strategies to meet current and future portfolio demands.; Lead transformation initiatives that improve scalability, efficiency, quality, and business impact.; Provide strategic oversight of start-up performance across the global portfolio.; Advise senior Clinical Development and TA leaders on portfolio feasibility, activation strategy, resource allocation, and execution risk.; Drive portfolio-level decision making through data-driven insights, predictive analytics, and scenario planning.; Champion modernization of study start-up through AI, automation, predictive analytics, and digital technologies.; Evaluate and scale emerging technologies, vendors, and innovative capabilities.; Represent Study Start-Up across governance forums and enterprise initiatives.; Influence enterprise priorities, organizational strategies, and ways of working impacting clinical development performance.; Build and sustain a high-performing leadership team through succession planning, talent development, and organizational effectiveness.; Develop future leaders and establish enterprise capability-building strategies.; Represent AbbVie in industry forums and strategic partnerships.; Monitor industry, regulatory, and competitive trends and translate insights into organizational strategy.

Requirements

Bachelor's degree required, advanced scientific or business degree preferred.; Minimum 15 years of pharmaceutical clinical development experience, including significant global leadership responsibility within Study Start-Up, Clinical Operations, or related functions.; Demonstrated success leading large global organizations and complex matrix environments; Proven experience developing organizational strategy and delivering transformational change at scale; Track record influencing executive leadership and driving enterprise-wide initiatives.; Expertise in global clinical development, study start-up strategy, regulatory environments, and portfolio management.; Experience leading digital transformation, AI adoption, automation initiatives, and operational excellence programs.; Strong financial, resource planning, workforce planning, and organizational design capabilities.; Exceptional executive communication, stakeholder management, and change leadership skills.